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eactive oxygen species (ROS) super-
oxide  and  hydrogen  peroxide  per-
form  important  signaling  functions  in 
many  physiological  and  pathophysi-
ological  processes.  Cell  senescence  and 
organismal  age  are  not  exemptions. 
Aging-regulating genes p66shc, Sirtuin, 
FOXO3a and Klotho are new important 
factors  which  are  stimulated  by  ROS 
signaling. It has been shown that ROS 
participate in initiation and prolongation 
of  gene-dependent  aging  development. 
ROS also participate in the activation of 
protein kinases Akt/PKB and extracellu-
lar signal-regulated kinase ERK, which 
by  themselves  or  through  gene  activa-
tion stimulates or retards cell senescence. 
Different retarding/stimulating effects of 
ROS might depend on the nature of sig-
naling species—superoxide or hydrogen 
peroxide.  Importance  of  radical  anion 
superoxide as a signaling molecule with 
“super-nucleophilic” properties points to 
the possibility of the use of superoxide 
scavengers (SOD mimetics, ubiquinones 
and flavonoids) for retarding the devel-
opment of aging.
Cellular  (replicative)  senescence  and 
organismal  senescence  (the  aging  of  a 
whole  organism)  are  characterized  by 
the  declining  ability  of  cells  to  respond 
to  oxidative  stress  and  correspondingly 
increase the risk of aging-associated dis-
eases. It has been supposed that senescent 
cells accumulate with age and by this con-
tribute to organismal aging. Such a view 
on the development of human aging was 
accepted by many authors and instigated 
the  search  for  methods  to  suppress  cel-
lular  senescence.  However,  it  should  be 
noted that the programmed mechanisms 
of senescence and apoptosis might prevent 
the conversion of normal cells into poten-
tial  cancer  cells  by  committing  suicide 
(apoptosis) or irreversibly arresting growth 
(senescence) rather than replicate.
Numerous  studies  demonstrate  an 
important role for reactive oxygen species 
(ROS) in the development of senescence 
and aging (Harman’s free radical theory 
of aging). There are different sources of 
superoxide,  a  precursor  of  other  ROS 
in  cells  such  as  mitochondria,  xanthine 
oxidase, NADPH oxidase and NO syn-
thases.1,2 It is usual practice to apply anti-
oxidants to reduce ROS damaging effects, 
however current studies demonstrate that 
ROS  possess  another  apparently  more 
important function: to be signaling mole-
cules in various enzymatic and gene-medi-
ated physiological and pathophysiological 
processes. In addition, the suppression of 
cellular senescence can enhance the possi-
bility of cellular transformation in immor-
tal cancer cells. Therefore, ROS-initiated 
apoptosis (programmed cell death) might 
result in an increase in longevity for the 
whole organism. Therefore, ROS signaling 
might be important in both suppression 
and stimulation of aging development.
Different Signaling Functions of 
Superoxide and Hydrogen  
Peroxide
Conflicting  effects  of  ROS  can  depend 
on  many  factors  including  ROS  chemi-
cal structures. ROS superoxide O2
.- and 
hydrogen peroxide H2O2 are major regu-
lators  and  signaling  molecules  in  cellu-
lar senescence. They belong to different 
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p66shc  gene  induced  stress  resistance 
and  prolonged  lifespan  in  experimental 
animals.9  For  example,  p66shc-/-  mice 
increased resistance to oxidative stress and 
resulted  in  a  30%  increase  in  lifespan. 
Further studies revealed the mechanism of 
p66shc activity.
It was agreed that the favorable effect 
of suppression of p66shc gene was due to 
its pro-oxidant activity. Shc locus encodes 
three  adaptor  proteins  (p46shc,  p52shc 
and p66shc) but only p66shc is regulated 
by ROS signaling. p66shc presents in both 
mitochondria and cytosol but only in mito-
chondria this enzyme is activated by ROS 
through the phosphorylation of a critical 
serine residue Ser-36 (Fig. 2). Pinton et 
al.10  has  shown  that  phosphorylation  is 
catalyzed by protein kinase Cβ which in 
turn was activated by ROS. Activation of 
mitochondrial p66shc shifts equilibrium 
between mitochondria and cytosol to the 
left  catalyzed  by  prolyl  isomerase  Pin1 
(Fig.  2).  This  gene/enzymatic  cascade 
results in a further increase in ROS for-
mation. Accumulation of p66shc in mito-
chondria changes mitochondrial calcium 
responses  and  induces  apoptosis.  These 
data show a new signaling route that acti-
vates an apoptotic inducer and shortens 
the life span.
Gertz et al.11 proposed another mecha-
nism  of  ROS  signaling  that  resulted  in 
the activation of p66shc protein (Fig. 3). 
These authors believe that under normal 
physiological conditions p66shc presents 
in reduced form in the cytosol. ROS acti-
vate  p66shc  by  oxidation  of  sulfhydryl 
groups to disulfide bridge and import it 
to  mitochondrial  intermembrane  space 
(IMS).  If  IMS  contains  sufficient  levels 
of  reductants  [supposedly  glutathione 
(GSH)  and  thioredoxcins  (Trx)],  they 
reduce p66shc into the inactive reduced 
form. If contents of reductants are small, 
then the activated oxidized p66shc protein 
generates ROS and initiates apoptosis.
It  has  also  been  suggested  that  ROS 
can activate p66shc by the dissociation of 
p66shc-heat shock Hsp70 protein inhibi-
tory complex in mitochondria and initi-
ate  apoptosis.12  Trinei  et  al.13  show  that 
p53-p66shc  signaling  pathway  regulates 
ROS formation, levels of oxidation-dam-
aged DNA and ROS-induced apoptosis. 
Giorgio et al.14 pointed out that p66shc 
signaling activates two distinct pathways 
of  ROS  generation:  hydrogen  peroxide 
regulated  extracellular  signal-regulated 
kinase  (ERK)  phosphorylation  (prolif-
erative  pathway)  and  superoxide  medi-
ated  TCR-stimulated  activation  of  the 
pro-apoptotic Fas ligand (FasL) promoter 
and subsequent cell death5 (Fig. 1). There 
are also other numerous examples of dif-
ferent effects of superoxide and hydrogen 
peroxide signaling in cellular processes.6-8 
It is therefore possible that, in part at least, 
the contradictory effects of ROS on aging 
processes depend on whether superoxide 
or  hydrogen  peroxide  are  the  signaling 
molecules in these processes.
Signaling by Reactive Oxygen 
Species in Gene- and  
Enzyme-Mediated Age  
Development
p66shc  gene.  It  was  demonstrated  in 
1999 that targeted mutation of the mouse 
classes of chemical compounds: superox-
ide is a paramagnetic free radical anion 
and hydrogen peroxide is a diamagnetic 
molecule. Therefore, their signaling and 
regulatory  functions  might  be  different. 
Superoxide is a “super-nucleophile,” and 
is able to participate in phosphorylation/
dephosphorylation  of  protein  kinases.3 
Hydrogen  peroxide  can  directly  inhibit 
protein phosphatases and by this activate 
protein kinases, but possibly more impor-
tantly hydrogen peroxide is able to stim-
ulate  superoxide-producing  enzymatic 
reactions.
Many  experimental  findings  confirm 
the  different  effects  of  superoxide  and 
hydrogen  peroxide  on  numerous  enzy-
matic  processes  including  apoptosis  and 
proliferation.  For  example,  it  has  been 
shown that superoxide increased mitogen-
activated  protein  kinase  (MAPK)  activ-
ity in cultured rat aortic vascular smooth 
muscle cell (VSMC) while hydrogen per-
oxide had no effect.4 T cell receptor (TCR) 
Figure 1. Different signaling effects of superoxide and hydrogen peroxide on enzymatic pro-
cesses.
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(CIDHP). CIDHP transfected with trun-
cated  HIV-1  construct  (NL4-3)  exhib-
ited the increased ROS formation, DNA 
strand breaks and a five-fold increase in 
apoptosis.  It  was  concluded  that  inhibi-
tion of phosphorylation at Ser-36-p66shc 
prevented the generation of HIV-1 stress 
signals  and  activation  of  the  CIDHP 
apoptosis program.
It is known that ROS and insulin sig-
naling in the adipose tissue stimulate aging 
and age-associated diseases. Berniakovich 
et al.21 found that insulin activated p66shc 
in adipocytes and that p66shc-generated 
ROS regulated insulin signaling through 
Akt  (protein  kinase  B)  phosphorylation 
and FOXO3a. Deletion of p66shc resulted 
in  increased  mitochondrial  uncoupling 
Ser-36 caused higher free radical produc-
tion and consequently the accumulation 
of damages by free radicals in age devel-
opment. The increased amount of Ser-36-
phosphorylated p66shc in livers of 12- and 
23-month-old  mice  was  correlated  with 
the decreased level of antioxidant enzymes. 
Khanday, et al.19 suggested that Ser-54 and 
Thr-386 are novel phosphorylatable resi-
dues in p66shc that regulated rac-induced 
increase  and  mediated  rac1-stimulated 
cellular oxidative stress and death.
Activation  of  p66shc  and  ROS  gen-
eration are the starting point of various 
pathologies. Husain et al.20 investigated a 
role for p66shc protein in HIV-1-induced 
ROS generation and apoptosis of immor-
talized  differentiated  human  podocytes 
is  a  redox  enzyme  that  generated  mito-
chondrial  hydrogen  peroxide  acting  as 
a  signaling  molecule  for  apoptosis  (Fig. 
4A).  These  authors  also  suggested  that 
p66shc is able to withdraw electrons from 
the mitochondrial electron transfer chain 
by the oxidation of cytochrome c. Nemoto 
et al.15 proposed that p66shc may regulate 
mitochondrial  metabolism  by  the  parti-
tion of ATP generation in the cells. In the 
absence of p66shc, the mitochondrial oxi-
dative pathway is reduced, whereas glyco-
lysis is increased.
A critical step of p66shc activation is 
the  phosphorylation  of  its  Ser-36  resi-
due.  This  process  depends  on  the  pro-
duction of ROS by various sources such 
as  the  advanced  glycation  end  products 
(AGEs),  hyperglycemia  (HG),  or  mito-
chondrial  protein  kinase  Cβ ( Fig.  4B). 
It has been shown that AGEs stimulate 
ROS  formation  in  diabetes  and  aging-
related  diseases.  Cai  et  al.16  investigated 
the effects of AGEs in human embryonic 
kidney  cells  (HEK293).  Stimulation  of 
HEK293 cells with AGEs caused Ser-36 
phosphorylation of p66shc and increased 
the  phosphorylation  of  protein  kinase 
Akt/B  and  FOXO3a  by  approximately 
threefold.  AGE-induced  phosphoryla-
tion of FOXO3a led to the inhibition of 
MnSOD which was strongly inhibited by 
an  antioxidant  (N-acetylcysteine).  This 
study  demonstrates  a  new  pathway  for 
prooxidant action of AGEs through Ser-
36 phosphorylation of p66shc, FOXO3a 
inactivation, and MnSOD suppression in 
human kidney cells.
Malhotra et al.17 found that the high 
glucose  (HG)-stimulated  adult  rat  ven-
tricular  myocytes  exhibited  a  marked 
increase in ROS production, upregulation 
of  (phospho-Ser-36)-p66shc,  collapse  of 
mitochondrial  transmembrane  potential, 
and increased formation of p66shcA/cyto-
chrome c complexes. These indices of oxi-
dative stress were accompanied by a 40% 
increase in apoptosis and the upregulation 
of  cleaved  caspase-3  and  the  apoptosis-
related proteins p53 and Bax.
It  was  found  that  the  Ser-36-phos-
phorylated  form  of  p66shc  increased 
with  the  age  of  experimental  animals.18 
The  level  of  Ser-36  phosphorylation  of 
p66shc continually enhanced in old mice. 
Increase  in  p66shc  phosphorylation  at   
Figure 3. Gertz’s mechanism of rOS activation of p66shc protein.11
Figure 4. (a) regulation by p66shc of rOS-induced apoptosis (Orsini et al.12 Trinei et al.13 and 
Giorgio et al.14). (B) rOS-mediated phosphorylation of p66shc and rOS signaling pathways of 
activation of FOXO3a and akt kinase and suppression of MnSOD (pinton et al.10 Cai et al.16 and 
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ε-(carboxymethyl)lysine (CML)-collagen-
induced  fibroblast  apoptosis.  Inhibition 
of p38 and JNK kinases reduced CML-
collagen-stimulated  apoptosis  while  the 
inhibition  of  the  phosphatidylinositol 
3-kinase/Akt pathway enhanced FOXO1 
activation. ROS suppression blocked p38 
and JNK stimulation by CML-collagen. 
These findings showed that FOXO1 was 
activated by the ROS-depended activation 
of p38 and JNK and inactivated by Akt 
kinase.
It  was  also  showed  that  the  insulin-
induced  PI3K/Akt  activation  pathway 
inhibited a family of forkhead transcrip-
tion  factors  (FOXO)  resulting  in  an 
increase in ROS formation in cells. Kim 
et al.31 studied the interaction of FOXO1 
with proinflammatory cytokine NFκB. It 
was found that the treatment of cells with 
insulin led to NFκB activation through 
the phosphorylation of FOXO1 by PI3K/
Akt pathway. It was suggested that dur-
ing aging the phosphorylation of FOXO1 
regulated NFκB nuclear translocation by 
activating PI3K/Akt.
Li et al.32 studied MnSOD expression 
and its transcriptional regulation in vascu-
lar smooth muscle cells (VSMC) isolated 
from old versus young rats grown in nor-
mal or high glucose or at different TNFα 
levels.  MnSOD  activity  was  reduced  in 
VSMC  from  old  compared  with  young 
animals. Inhibition of FOXO3a transcrip-
tion led to a reduction in MnSOD gene 
expression. VSMC from old rats increased 
the phosphorylation of FOXO3a at Ser-
253  which  paralleled  the  reduction  of 
MnSOD protein. Treatment of cells with 
IGF-1  induced  phosphorylation  of  Akt 
and  FOXO3a.  Akt  activity  increased  in 
VSMC from old rats and by this initiated 
the  phosphorylation  and  inactivation  of 
FOXO3a and downregulation of MnSOD 
transcription.
In subsequent work, Li et al.33 studied 
the effect of insulin-like growth factor-1 
receptor  (IGF-1R)  on  the  Akt/FOXO3a 
and ERK pathways in VSMC from young 
and old rats. They found the constitutive 
activation of IGF-1R in VSMC from old 
compared to young rats. IGF-1R signaling 
modulated  MnSOD  and  catalase  genes 
through  activation  of  the  Akt/FOXO3a 
pathway. Activation of IGF-1R signaling 
influenced VSMC function in old rats and 
is considered to be a regulator of longevity 
and cancer (Fig. 5). However, the other 
FOXO proteins, for example FOXO1, are 
apparently  also  capable  of  participating 
in ROS-dependent cascades (see below). 
It has also been proposed that FOXO3a 
phenotype is associated with a longer life 
in humans.24 In mammal cells, FOXO3a 
is predominantly in the nucleus, but ROS 
initiates its redistribution to the cytosol.25 
Miyauchi et al.26 proposed that FOXO3a 
plays an important role in the enzymatic-
gene cascade insulin/insulin-like growth 
factor-1  (IGF-1)/phosphatidylinositol-3 
kinase  (PI3K)/Akt/FOXO3a.  In  mam-
malian cells the activation of this signal-
ing pathway leads to senescence. Guo et 
al.27  showed  that  p66shc  participates  in 
an α1-adrenergtic receptor (α1-AR) path-
way that requires the cooperative effects 
of protein kinases PKCε and PKCδ and 
leads to Akt-FOXO3a phosphorylation in 
cardiomyocytes. α1-AR stimulated ROS-
dependent  p66shc  phosphorylation  that 
required epidermal growth factor recep-
tor  (EGFR)  and  PKCε  activity.  p66Shc 
linked α1-AR to an Akt signaling pathway 
that selectively inactivated FOXO3a and 
downregulated  mitochondrial  MnSOD. 
Thus  this  and  other  studies  demon-
strate  that  ROS  phosphorylation/acti-
vation  of  FOXO3a  resulted  in  cellular 
senescence.27-29
It is known that AGEs are elevated in 
aged  and  diabetic  individuals.  Alikhani 
et  al.30  demonstrated  that  proapoptotic 
transcription  factor  FOXO1  stimulated 
and reduced triglyceride accumulation in 
adipocytes and in vivo increased metabolic 
rate and decreased fat mass and resistance 
to diet-induced obesity.
It has been found that NADPH oxidase 
in macrophages of p66shc-knockout mice 
p66shc(-/-) mice decrease superoxide pro-
duction by 40%.22 The rate of phosphory-
lation of p47phox decreased in mutants, as 
well as the membrane translocation of this 
complex. It was possibly due to a decrease 
in the phosphorylation of protein kinasee 
Cδ, Akt/B and ERK that was responsible 
for the phosphorylation of p47phox.
It has been noted above that Shc locus 
encodes  three  adaptor  proteins  (p46shc, 
p52shc  and  p66shc)  but  only  p66shc  is 
regulated  by  ROS  signaling.  However, 
Arany et al.23 demonstrated that all three 
proteins  can  participate  in  the  regula-
tion  of  oxidative  stress.  They  showed 
that  tyrosine-phosphorylated  p46shc 
and p52shc proteins activated epidermal 
growth factor receptor EGFR and corre-
spondingly  the  EGFR/Ras/MEK/ERK 
survival  pathway,  whereas  the  p66shc 
protein  inhibited  their  functions.  Thus 
in  order  to  ameliorate  oxidative  stress-
induced cell injury it might be useful to 
inhibit Ser-36 phosphorylation of p66shc 
or knock down p66shc expression in vivo.
FOXO3a gene. FOXO3a belong to the 
O subclass of the forkhead family of tran-
scription factors which are characterized by 
a fork head DNA binding domain. There 
are three main proteins (FOXO1, FOXO3a 
and FOXO4) from which FOXO3a protein 
Figure 5. Forkhead family of transcription factors.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  81
comprise  a  mitochondrial  signaling  sur-
vival cascade.
KLOTHO gene. The Klotho gene was 
identified by Kuro-o et al.42 in 1997. It has 
been shown at the beginning that Klotho 
controls  the  sensitivity  of  organism  to 
insulin  but  later  on  this  gene  attracted 
particular  attention  for  its  involvment 
in aging processes. Klotho protein exists 
in  two  forms:  the  transmembrane  form 
expressed primarily in renal tubular cells 
and the secreted form circulating in the 
blood.43
Yamamoto  et  al.44  studied  signaling 
pathways through which Klotho increased 
resistance to oxidative stress. Cell surface-
bound Klotho inhibited FOXO3a phos-
phorylation  and  promoted  its  nuclear 
translocation. The nuclear FOXO3a then 
high levels of Sirt1 increased ROS forma-
tion in the heart (Fig. 7).
Hasegawa  et  al.40  studied  the  role  of 
Sirt1 in ROS-depended renal tubular cell 
apoptosis.  Hydrogen  peroxide  induced 
FOXO3a nuclear accumulation and apop-
tosis while endogenous Sirt1 maintained 
cell survival by regulating catalase expres-
sion.  Subauste  and  Burant  showed  that 
upregulation of Sirt1 stimulated the trans-
location  of  FOXO1  to  the  nucleus  and 
increased  FOXO1  protein  levels  in  adi-
pocytes exposed to FFA.38 Jacobs et al.41 
found  that  Sirt3  forms  a  complex  with 
FOXO3a  in  mitochondria.  Expression 
of Sitr3 deacetylation mutant in cells led 
to an increase in intracellular superoxide 
production  and  oxidized  glutathione.  It 
was suggested that Sirt3 and FOXO1 can 
may contribute to the increased risk for 
atherosclerosis. It has been proposed that a 
decrease in FOXO3a expression is respon-
sible for age-accelerated atherosclerosis in 
old mice.34
Tan et al.35 proposed that FOXO3a is 
able  to  inhibit  cardiomyocyte  hypertro-
phy through the transactivation of cata-
lase.  Nakamura  and  Sakamoto  showed 
that  hydrogen  peroxide  stimulated  the 
expression and phosphorylation of FOXO 
resulting  in  the  induction  of  luteal  cell 
apoptosis.36  It  was  found  that  hydrogen 
peroxide induced FOXO3a accumulation 
in  the  nucleus  causing  the  transactiva-
tion of IRS promoter activity and ROS-
induced apoptosis in mammalian cells. As 
it  follows  from  already  considered  data, 
p66shc  and  FOXO3a  may  participate 
jointly in ROS stimulation. Chintapalli et 
al.37 showed that the inhibition of p66shcA 
in mesangial cells prevented glycooxidant-
dependent FOXO3a regulation and pro-
moted the survival phenotype.
It  was  found  that  that  the  increased 
flux of free fatty acids (FFA) in adipocytes 
increased  mitochondrial  ROS  produc-
tion and decreased the levels of FOXO1 
and transcription of antioxidant enzymes 
MnSOD  and  glutathione  peroxidase.38 
Resveratrol  protected  cells  from  FFA-
induced  ROS  formation  by  increasing 
FOXO1/Sirt1-dependent  MnSOD  and 
glutathione peroxidase activation. (Some 
FOXO-depended enzymatic pathways are 
presented in Fig. 6).
Gene family SIRTUIN. S ilen t info r -
mation  regulator  Sirtuin  (human  Sirt1 
and  Sirt3  and  yeast  Sir2)  proteins  are 
deacetylases hydrolyzed acetyl-lysine resi-
dues. Sirt2 protein mediates longevity of 
yeast but the effect of Sir1 on the lifespan 
of mammals is still uncertain. Alcendor 
et al.39 showed that Sirt1 was significantly 
upregulated in response to low/moderate 
oxidative  stress  in  nontransgenic  adult 
mouse  hearts.  This  Sirt1  upregulation 
suppressed age-dependent cardiac hyper-
trophy,  apoptosis,  cardiac  dysfunction, 
and expression of senescence markers. In 
contrast, a high level of Sirt1 enhanced 
these damaging disorders. Moderate over-
expression of Sirt1 protected from ROS 
overproduction by paraquat and increased 
the  expression  of  catalase  through 
FOXO3a-dependent  mechanisms,  while 
Figure 6. rOS-depended gene/enzyme cascades leading to activation/inactivation FOXO genes 
(Miyauchi et al.,26 Guo et al.27 and purdom and Chen28).
Figure 7. rOS-depended Sitruin pathways (alcendor et al.,39 Hasegawa et al.40 and Jacobs et al.41).82  Oxidative Medicine and Cellular Longevity  Volume 3 issue 2
factors  (environmental  contamination, 
irradiation,  etc.,),  pathological  disorders 
or toxic components of diet can stimulate 
cell  senescence.51  As  it  follows  from  the 
present  consideration,  ROS  signaling  is 
responsible for the initiation of gene- and 
enzyme-mediated cascades of senescence 
and aging. It is of utmost importance that 
reactive oxygen species are not only the 
initiators  of  these  cascades  but  are  also 
formed during these processes; owing to 
this, ROS signaling results in ROS over-
production and the acceleration of aging.
Contemporary studies demonstrate an 
astonishing phenomenon: a cooperation of 
ROS and aging-regulating genes in senes-
cence and aging development. For a long 
time both ROS and genes were considered 
to be the important but separate stimuli of 
aging regulation, but it is now clear that 
they are interconnected. Numerous stud-
ies  demonstrate  the  signaling  functions 
of superoxide and hydrogen peroxide in 
various  enzymatic  heterolytic  processes.2 
Unfortunately  at  present,  the  mecha-
nisms of ROS signaling in these reactions 
remains  obscure.  A  rare  example  of  the 
investigation of ROS signaling is the study 
of activation of protein kinase C by super-
oxide and hydrogen peroxide through the 
oxidation of thiol restudies and the release 
of  zinc  from  the  cysteine-rich  region  of 
the enzyme.52 Superoxide probably plays a 
critical role in PKC activation due to its 
ability to substitute zinc ion in the enzyme 
domain.  However,  in  many  other  cases 
no suggestions have been made about the 
mechanism of ROS signaling in the enzy-
matic non-free radical processes.
It  has  been  shown  that  ROS  signal-
ing  in  gene-regulated  aging  processes  is 
mediated by enzymes. For example, lower 
survival  of  hepatocytes  from  aged  rats 
was  associated  with  reduced  activations 
of ERK and Akt kinases, which protected 
against oxidant injury.53 Correspondingly, 
the inhibition of ERK and Akt activation 
in  young  cells  markedly  increased  their 
sensitivity to hydrogen peroxide whereas 
caloric restriction (surviving factor) pre-
vented loss in ERK and Akt activation and 
enhanced survival of old hepatocytes.
Jin et al.54 investigated ROS-dependent 
signal transduction pathways in the kid-
ney of young and aged rats. Menadione-
induced  PI3-kinase  activity  and  Akt 
Rakugi  et  al.49  studied  the  effects  of 
membrane-bound  Klotho  on  MnSOD 
expression and nitric oxide production in 
human  umbilical  vein  endothelial  cells 
(HUVEC). They found that the treatment 
of HUVEC with special klotho expression 
vectors  enhanced  MnSOD  expression  by 
approximately two-fold, partially through 
the  activation  of  cAMP  signaling  path-
way and increased nitric oxide production. 
In  addition  klotho  inhibited  angiotensin 
II-induced ROS production in HUVEC.
It has been shown that the Klotho gene 
is mainly expressed in the kidney tubules. 
Therefore  the  reduction  of  Klotho  gene 
expression may contribute to the develop-
ment of kidney failure while its overex-
pression may lead to the amelioration of 
renal injury. Haruna et al.50 showed that 
the survival rate of old Klotho transgenic 
mice was approximately 30–70% higher 
than that in wild-type mice. This improve-
ment  was  associated  with  improvement 
in renal functions, cytochrome c oxidase 
activity, and the reduction of superoxide 
generation. It was proposed that Klotho 
may serve as a circulating hormone capa-
ble of suppressing mitochondrial oxidative 
stress.
Discussion
Under  normal  physiological  conditions 
the  human  organism  tightly  controls 
all  the  sources  of  ROS  production  and 
the  damaging  leak  of  ROS  leading  to 
various  pathologies  and  aging  should 
be  minimal.  However  various  external 
became  bound  to  the  MnSOD  promoter 
and  upregulated  its  expression,  resulting 
suppression ROS formation. Thus Klotho 
protein can suppress aging trough two dis-
tinct mechanisms: the inhibition of insulin-
like signaling and an increase in resistance to 
oxidative stress (Fig. 8).
Kurosu  et  al.45  demonstrated  that  the 
defect  in  Klotho  gene  expression  in  mice 
accelerated cellular senescence, on the other 
hand the overexpression of Klotho in mice 
extended life span. Administration of angio-
tensin II to rats decreased renal expression of 
klotho and caused abnormal iron deposition 
in renal cells. Saito et al.46 investigated the 
effects of iron overload and iron chelation on 
renal expression of klotho in untreated rats 
and rats treated with angiotensin II. Their 
findings suggested that iron overload and 
increased ROS overproduction were involved 
in the mechanism of angiotensin II-mediated 
modulation of klotho expression.
Ohta  et  al.47  investigated  the  effect  of 
Klotho gene delivery on blood pressure and 
oxidative  stress  in  vivo.  They  found  that 
Klotho  gene  upregulated  MnSOD  expres-
sion and total SOD activity in the aorta of 
mice,  enhanced  nitric  oxide  production, 
and downregulated lipid peroxide concen-
tration in serum of mice. It was concluded 
that klotho gene infusion into the tail vein 
of mice and rats suppressed ROS formation 
in animals.
Klotho overexpression in mice decreased 
hydrogen  peroxide-induced  apoptosis  in 
endothelial cells and interfered with hydro-
gen  peroxide-induced  premature  cellular 
senescence.48
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aging suppressors.57-59 There are also other 
free radical scavengers which rapidly react 
with superoxide (flavonoids and ubiquino-
nes), which can probably also be used as 
aging-retardant antioxidants.60,61
As is seen from the above, phosphory-
lation of the p66shc gene leads to its acti-
vation and the stimulation of senescence. 
On  the  other  hand,  phosphorylation  of 
FOXO3a  results  in  the  inhibition  of  its 
anti-aging activity. It is of particular inter-
est that the Sirtuin gene downregulated 
senescence at low ROS levels and stimu-
lated it at high ROS levels. Klotho appar-
ently  always  exhibits  antioxidant  effect. 
There could be major conclusions about 
pro-  and  anti-aging  effects  of  p66hsc, 
FOXO3a, Sirtuin and Klotho genes.
In addition to gene regulation there is 
another factor capable of retarding aging 
development. It has been shown that the 
formation  and  bioavailability  of  nitric 
oxide was decreased in old human and ani-
mals.62-65 On the other hand, it has been 
shown that the Klotho gene enhanced NO 
formation in human and animal cells.47,49 
Therefore, we can hypothesize that both 
anti-aging genes and nitric oxide are criti-
cal factors of aging development.
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